CompletedNCT05643027
Acceptance therapy for cancer patients at risk of opioid misuse
About this title
Read the official source — NCT05643027Behavioural studyAges 18–99United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 99 years.
- Listed locations
- BostonSee all locations and recruitment
Study information
Study start dateStarted: March 1, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Dana-Farber Cancer Institute
- Sponsor type
- Research institute
- Study type
- Behavioral
- Intervention type
- Behavioural
- Locations
- United States
- Age range
- From 18 Years to 99 Years
- Official registry ID
- NCT05643027
- Official title
Show the full official title
A Novel Intervention for Avoidance-Related Opioid Misuse in Patients With Cancer
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Dana-Farber Cancer Institute, a research institute.
Who was this study for?
Listed age limits: 18 years to 99 years.
